Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Hepatitis

A Drug That Could Functionally Cure Hepatitis B Achieved That Goal in 1 in 5 Patients in Two Major Phase 3 Trials

Phase 3 B-Well trials published in NEJM showed bepirovirsen achieved functional cure in 20% of chronic hepatitis B patients — the first phase 3 evidence of this kind for the disease.

Medical Daily

Bipartisan bill to eliminate hepatitis C unveiled in House

A bipartisan pair of House members is introducing legislation aimed at treating millions of Americans of a deadly-but-curable liver disease, the culmination of a yearslong push from public health advocates. The bill, sponsored by Reps. Mariannette Miller-Meeks, R-Iowa and Diana DeGette, D-Colo., would create a national hepatitis C elimination program to expand…

Roll Call

Global Cancer Cases Could Reach 35 Million a Year by 2050 as Population Growth and Aging Drive a 67% Surge

Global Cancer Statistics 2026 projects 34 million cancer cases by 2050, a 67% increase. Nearly 21 million cases in 2024, 9.8 million deaths. Lung cancer remains the top killer.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

7 Monsoon Illnesses That Look Like a Mild Fever but Carry a Serious Infection Risk in India

DengueA 2023 report from the National Centre for Vector Borne Diseases Control recorded over 289,000 dengue cases across India in a single year, with the sharpest spikes running from July through October. The fever that arrives with it, sudden, high, accompanied by pain behind the eyes and aching joints, is…

Times Life

WHO Issues Urgent Warning as Global Cancer Cases Could Nearly Double by 2050

Almost everyone knows someone whose life has been changed by cancer. It could be a parent, a friend, a neighbour, or even someone you've never met but admired. That's what makes the World Health Organization's latest warning feel so personal. According to new projections, the number of people diagnosed with…

MyLifeXP

Fake Vaccine Records for 162 Children? Historic Penalty Highlights Hidden Public Health Risks Beyond COVID-19

New York imposed a historic penalty after fake vaccination records for 162 children exposed risks to disease prevention and public health surveillance.

Medical Daily

Idaho Mother Accused of Killing Her Twins Faces Hearing as Defense Blames Vaccines

An Idaho mother was indicted June 29 on two counts of first-degree murder after prosecutors say she suffocated her 18-month-old twins. Court date is July 14.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

Labour MPs fear infected blood scandal is ‘another fine mess’ left for Burnham to clear up

Andy Burnham, who has long campaigned for victims of the scandal, has criticised how the compensation scheme will operate

The Independent UK

Syringe services in limbo under Trump, risking hepatitis C progress

A decade after Congress first allowed federal funding to support clean needle programs, the Trump administration is backing off that policy, potentially risking progress made against hepatitis C, a deadly but curable virus mostly spread by people who inject drugs. The administration now says funding can no longer support programs such as…

Roll Call

If You Have Chronic Hepatitis B, a New FDA Approval Means You Should Ask About This Dangerous Co-Infection

A new FDA approval for Hepatitis Delta treatment means chronic hepatitis B patients should now ask about HDV testing. Here's why testing matters more than ever and who should ask.

Medical Daily

The FDA Approves the First-Ever Hepatitis Delta Treatment: Here's Why Hepatitis B Patients Should Get Tested

FDA approved bulevirtide May 22, 2026 — the first-ever Hepatitis Delta treatment. About 80,000 Americans have HDV. Here's who should ask for testing and what the approval means.

Medical Daily

Liver cancer deaths are rapidly increasing – tackling preventable causes would save lives

Liver cancer is one of the fastest rising causes of cancer-related deaths in the UK, and the third leading cause of cancer deaths worldwide.

The Conversation

Hepatitis Delta Is the Deadliest Form of Viral Hepatitis — and the U.S. Just Got Its First Treatment for It

FDA granted accelerated approval to Hepcludex (bulevirtide) for Hepatitis Delta on May 22, 2026 — the first-ever U.S. treatment for HDV. What patients need to know.

Medical Daily

7 Vaccines Doctors Recommend for Adults Over 50

Turning 50 often comes with new priorities, and protecting your health moves higher on the list. While many people focus on exercise, diet, and preventive...

Saving Advice

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

Hepatitis A Outbreak in Canada Leaves 4 Dead, 142 Hospitalized; CDC Issues Travel Notice as Many Americans Traveling to Canada Remain Unvaccinated.

The CDC issued a hepatitis A travel notice for Manitoba, Canada on June 4, 2026. The outbreak has grown to 658 cases, 142 hospitalizations, and 4 deaths since April 2025. Winnipeg restaurant exposures have been identified. Here is what U.S. travelers need to know before visiting Canada.

Medical Daily

San Diego's Unhoused Population Faces Simultaneous Hepatitis A and Mpox Threats — Health Officials Urgently Expanding Vaccination Access

San Diego health officials are escalating vaccination efforts as hepatitis A and mpox cases rise simultaneously among the city's large unhoused population. Officials report cases in downtown encampments.

Medical Daily

FDA Warns New Yorkers: Hepatitis A Linked to Frozen Blood Clams Sold in New York State — Illnesses Span Months

The FDA issued a public alert about hepatitis A-linked blood clams distributed in New York. Cases traced to La Serranita frozen blood clams imported from Ecuador. First illness reported in July 2025.

Medical Daily

The U.S. Was on Track to Eliminate Hepatitis C by 2030 — Then Came the Federal Public Health Cuts That Are Dismantling the Programs Doing It

Federal public health cuts are jeopardizing hepatitis C elimination programs in California, putting testing and curative treatment access at risk.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data Ahead

Assembly Biosciences (NASDAQ:ASMB) outlined its antiviral and liver disease development strategy during a fireside chat at the 47th Annual Goldman Sachs Healthcare Conference, highlighting upcoming decisions tied to its herpes simplex virus type 2 program, expansion of its hepatitis delta candidate

MarketBeat

Assembly Biosciences Eyes Gilead HSV Plan as ABI-6250 Liver Pipeline Expands

Assembly Biosciences (NASDAQ:ASMB) is awaiting a key development plan from partner Gilead Sciences for its herpes simplex virus programs while advancing ABI-6250 into multiple liver disease indications, Chief Executive Officer Jason Okazaki said during a Jefferies biotech event. Okazaki said 2024 w

The Economic Times

What killed Beethoven? His own DNA finally answered after 200 years, with a bombshell twist

A groundbreaking genetic study has provided new insights into the life and death of composer Ludwig van Beethoven nearly 200 years after his passing. Researchers analyzed DNA from authenticated hair samples and found evidence of inherited liver disease risk factors and a hepatitis B infection that may have contributed to…

Medical Daily

First-in-Class Hepatitis B Drug Shows Promise for 'Functional Cure' in Early Trials

An experimental new treatment for chronic hepatitis B is raising hopes for what researchers call a potential "functional cure," a milestone that could change how the viral liver disease is managed in the future.

AAP

Experimental hepatitis B drug may offer 'functional cure' for some patients

New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus

The Economic Times

GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studies

GSK's experimental hepatitis B drug, bepirovirsen, showed promising results in late-stage studies, with nearly one in five patients achieving a functional cure after six months of treatment. This offers a potential finite treatment course, a significant advancement over lifelong antiviral pills for the over 250 million people globally living with…

AAP

Experimental hepatitis B drug might offer 'functional cure' for a subset of patients

New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus

1 2 3 4 5

People

Mariannette MillerMeeks

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

the American Cancer Society

112 stories

the American Academy of Pediatrics

106 stories

PBC

81 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.